Adverse event [GxP / QC / QA]

posted by Bhavesh – India, 2009-08-17 09:41 (5746 d 19:04 ago) – Posting: # 4050
Views: 5,567

Dear KK,

I agree with you but confusion arise during report preparation. Under which treatment I shall consider it. because we specify AE in percentage respective of treatment and based on that final conclusion will drawn.

Bhavesh Shah


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
113 visitors (0 registered, 113 guests [including 12 identified bots]).
Forum time: 04:46 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5